|
|
|
Insider
Information: |
Alton Gregg H |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
61,846 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,932,241 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
61,846 |
|
|
Total
Value |
$3,932,241 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,710 |
57,327 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2009-02-03 |
4 |
A |
$52.01 |
$119,623 |
D/D |
2,300 |
54,696 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,710 |
55,406 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,424 |
29,480 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,350 |
38,487 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,020 |
40,157 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
49,790 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
40,790 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
21,332 |
56,270 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
86,548 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
33,246 |
87,516 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2014-02-14 |
4 |
A |
$21.94 |
$21,243 |
D/D |
968 |
86,484 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
189,484 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-02-13 |
4 |
A |
$85.61 |
$21,232 |
D/D |
248 |
111,942 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
104,274 |
216,216 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-02-15 |
4 |
A |
$76.02 |
$18,854 |
D/D |
248 |
129,670 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
55,206 |
184,876 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
123,279 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,716 |
130,995 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
38,078 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
19,992 |
58,070 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
19,151 |
63,577 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Patient Officer |
|
2019-02-15 |
4 |
A |
$57.45 |
$18,959 |
D/D |
330 |
58,046 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2006-08-17 |
4 |
AS |
$64.05 |
$228,014 |
D/D |
(3,550) |
28,486 |
|
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2006-09-01 |
4 |
AS |
$63.13 |
$225,704 |
D/D |
(3,550) |
24,936 |
|
- |
|
360 Records found
|
|
Page 1 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|